In summary, the interaction between HMGCR and TNF-α exhibits varying intensity and biological consequences depending on tumor type (e.g., breast cancer subtypes, glioblastoma) and differences in the immune microenvironment (macrophage polarization, T cell infiltration levels). Here, HMGCR is linked to breast carcinoma.